13th Cold Chain GDP & Temperature Management Logistics Summit – Canada

Print Friendly

Hilton Montreal Bonaventure, Montreal, Quebec
February 23 – 26, 2015

The 13th Annual Cold Chain GDP & Temperature Management Logistics Summit – Canada, is the largest event of its kind for life sciences in the Canadian market. The program has been expanded to cover clinical supply, biologics, supply chain integrity and small pharma/biotech supply chains, to better address the Canadian and Montreal markets. Attendees will have access to supply chain stakeholders in world-class companies operating in pharmaceuticals, health technologies, biotechnology and contract manufacturing/research.

Kevin O’Donnell, BioLife’s Vice President, Cold Chain Standards, Practices & Compliance, will present Web-Connected Biologistics: Cold Chain Lessons Learned from the Pharmaceutical Industry and how SMART Shippers have Come of Age; Wednesday, February 25, 2015 | Main Conference Day 1.

Go to Event Site

 

Phacilitate’s Cell & Gene Therapy Forum 2015

Print Friendly

Washington, DC
January 26-28, 2015
BioLife Booth #68

Phacilitate’s Cell & Gene Therapy Forum is the world’s biggest and fastest growing cell & gene therapy business meeting. It is the leading event driving product commercialization, and draws the most senior audience of any cell & gene event, with 76% Director level and above.

BioLife’s Aby J. Mathew, Ph.D., has been selected to chair Focus Session 2, Day 1, and will present Logistics 1: Placing logistics at the heart of the cell & gene therapy business model. His presentation will focus on maximizing quality control and minimizing ‘Cost of Logistics’ for cell and gene therapy products.

Go to Event Site

ECI Scale-Up and Manufacturing of Cell-Based Therapies IV

Print Friendly

San Diego, CA
January 18-22, 2015

The fourth annual conference on Scale-Up and Manufacturing of Cell-Based Therapies is scheduled for January 18-22, 2015 and will take place at the Hyatt Regency in San Diego.

This conference will focus on process development, scale-up, and manufacturing of cell-based therapies and will bring academicians, clinicians, industry leaders, and regulators from all over the world together to discuss the most critical scientific and engineering challenges in this field. The conference aim is to continue to play a central role in defining and refining the engineering sciences of cell-based therapies.

BioLife’s Senior Vice President and Chief Technology Officer, Aby J. Mathew, PhD, will present Biopreservation and Biologistics Considerations for GMP Manufacturing during Session 5: Industrial Highlights: Cell therapy manufacturing and implementation solutions.

Go to Event Site

TERMIS-AM

Print Friendly

December 13-16, 2014
Renaissance Hotel
Washington, DC

The TERMIS-AM Meeting is the key annual meeting held in the Americas each year, and brings together over 800 researchers, scientists, trainees, and students from both academia and industry to discuss critical developments in the field. The meeting is led by keynote speakers each day, and consists of parallel technical sessions as well as poster presentations. A strong role in the meeting planning and execution will be played by the TERMIS-AM Student and Young Investigator Section (SYIS).

BioLife Solutions is sponsoring this year’s Commercialization & Regulation TWIG Business Plan Competition.

Go to Event Site

IBC’s Inaugural Commercialization of Cell, Gene & Immunotherapies Conference

Print Friendly

Accelerating the Translation of Commercially Viable, Cell, Gene, and Immunotherapies Through Bioprocess Tools and Technologies

December 11-12, 2014
Andaz San Diego
San Diego, California

This new event will cover the exciting progress to accelerate the translation of commercially viable cell, gene and immunotherapies through the implementation of novel bioprocessing tools and technologies.

Aby J. Mathew, Ph.D., Senior Vice President & Chief Technology Officer, BioLife Solutions, will present Biologistics Considerations for Commercial GMP Manufacturing, Friday, December 12th at 2:00 PM.

Go to Event Site

AABB Annual Meeting 2014

Print Friendly

AABB2014

Booth 1533

As the premier event for the transfusion medicine and cellular therapies industry, attendees will learn the latest in transfusion medicine and cellular therapies, advance their career, explore state-of-the-art products and services and network with colleagues. The event boasts approximately 6,000 attendees, over 120 educational sessions, approximately 700 scientific and administrative abstracts, and an exhibit hall filled with nearly 200 companies.

BioLife’s Senior Vice President and Chief Technology Officer, Aby J. Mathew, PhD, will serve as a Table Moderator during the meeting session entitled “The So-Cell Network”: Round Table Discussions for Cellular Therapy Professionals.
Topic: “Cell Concentration During Cryopreservation: Does It Matter?”
Saturday, October 25, 2014
4:00 – 5:30 pm

BioLife Solutions will, once again, sponsor the Cellular Therapy Sizzling Topics Luncheon:
Sunday, October 26
Noon – 2:00 pm
(Included in registration fee, ticket required for entry)

Go to Event Site

 

BEST Meeting XLVIII

Print Friendly

The College of Physicians of Philadelphia
Philadelphia, PA
October 22-23, 2014

The Biomedical Excellence for Safer Transfusion (BEST) Collaborative is an international research organization that works collaboratively to explore ways to improve transfusion-related services through standardization of analytic techniques, development of new procedures, systematic review of evidence, and execution of clinical and laboratory studies. BEST currently operates in teams covering five areas: Conventional Blood Components, Transfusion Safety, Clinical Studies, Cellular Therapy, and our newest team, Donor Studies.

The meeting is open to all BEST Collaborative members and will be attended by BioLife’s Senior Vice President and Chief Technology Officer, Dr. Aby J. Mathew.

Stem Cell Meeting on the Mesa

Print Friendly

La Jolla, CA
October 7-9, 2014

The Stem Cell Meeting on the Mesa is a three-day conference bringing together senior executives and top decision-makers in the regenerative medicine and advanced therapies industry with the scientific community to advance cutting-edge research into cures. The meeting features a nationally recognized Scientific Symposium, attended by leading researchers and clinical experts from around the globe, in conjunction with the industry’s premier annual Partnering Forum, the first and only event of its kind dedicated solely to facilitating connections in this sector. Combined, these meetings attract nearly 800 attendees, fostering key partnerships through more than 500 one-on-one meetings while highlighting the significant clinical and commercial progress in the field over the past year.

A Company Presentation will be given by Mike Rice, President and CEO, BioLife Solutions.
Oct. 8 | 2:15 pm | La Jolla Ballroom 2

Go to Event Site

12th Annual Cold Chain GDP & Temperature Management Logistics Global Forum

Print Friendly

Dates: September 29 – October 03, 2014

Location: John B. Hynes Veterans Memorial Convention Center, Boston, Massachusetts

The Global Forum will examine the modern cold chain – including all temperature range products and their global GDP REQUIREMENTS – as well as an expanded focus on SUPPLY CHAIN INTEGRITY.

Representatives from BioLife Solutions will present: Adoption of optimized biopreservation tools to improve cold chain logistics for thermally sensitive biologics during the 5:40 pm session, all tracks, on October 1st.

Attendees may visit with BioLife representatives in Booth 107, and also at the BioLife sponsored Cocktail Reception on October 1st @ 5:50 pm.

Go to event site

TERMIS Webinar: “Biopreservation: Cryopreservation and Non-Frozen Storage for GMP Regenerative Medicine.”

Print Friendly

Thursday, August 7th – Aby J. Mathew PhD, BioLife Solutions Inc.

Webinar announcement from Chris Gemmiti, PhD, TERMIS

Please join me for our next Commercialization TWIG webinar on Thursday August 7th at 12PM PDT / 3PM EDT, where Aby J. Mathew PhD, Senior Vice President & Chief Technology Officer of BioLife Solutions Inc will be presenting “Biopreservation: Cryopreservation and Non-Frozen Storage for GMP Regenerative Medicine.” The presentation will last about 30 minutes, with ample time for Q&A.

Attendance is limited to 25, and you must register in advance so that I can send you the password. Registering takes less than one minute and can be done here:
https://www.surveymonkey.com/s/GPZ5FL5

TERMIS (Tissue Engineering and Regenerative Medicine International Society) is an international learned society. Its goal is the worldwide advancement of both the science and technology of tissue engineering and regenerative medicine. The Society promotes education and research within the field of tissue engineering and regenerative medicine through regular meetings, publications and other forms of communication. The Society also serves as an international forum to promote the informed discussion of challenges and therapeutic benefits of the application of tissue engineering and regenerative medicine technologies.